DE3750140D1 - Inhibierung der interleukin-1-bildung durch monocyten und/oder makrophagen. - Google Patents

Inhibierung der interleukin-1-bildung durch monocyten und/oder makrophagen.

Info

Publication number
DE3750140D1
DE3750140D1 DE3750140T DE3750140T DE3750140D1 DE 3750140 D1 DE3750140 D1 DE 3750140D1 DE 3750140 T DE3750140 T DE 3750140T DE 3750140 T DE3750140 T DE 3750140T DE 3750140 D1 DE3750140 D1 DE 3750140D1
Authority
DE
Germany
Prior art keywords
monocyten
macrophage
interleukin
inhibition
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3750140T
Other languages
English (en)
Inventor
Paul Bender
Don Griswold
Nabil Hanna
John Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
SmithKline Beecham Corp
Original Assignee
GlaxoSmithKline LLC
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC, SmithKline Beecham Corp filed Critical GlaxoSmithKline LLC
Application granted granted Critical
Publication of DE3750140D1 publication Critical patent/DE3750140D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE3750140T 1986-08-19 1987-08-17 Inhibierung der interleukin-1-bildung durch monocyten und/oder makrophagen. Expired - Lifetime DE3750140D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89790986A 1986-08-19 1986-08-19
US07/063,550 US4794114A (en) 1986-08-19 1987-06-17 Inhibition of interleukin-1 production by monocytes and/or macrophages
PCT/US1987/002014 WO1988001169A1 (en) 1986-08-19 1987-08-17 Inhibition of interleukin-1 production by monocytes and/or macrophages

Publications (1)

Publication Number Publication Date
DE3750140D1 true DE3750140D1 (de) 1994-07-28

Family

ID=26743522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750140T Expired - Lifetime DE3750140D1 (de) 1986-08-19 1987-08-17 Inhibierung der interleukin-1-bildung durch monocyten und/oder makrophagen.

Country Status (10)

Country Link
US (1) US4794114A (de)
EP (1) EP0321490B1 (de)
JP (1) JPH01503782A (de)
AT (1) ATE107507T1 (de)
AU (1) AU7880087A (de)
CA (1) CA1292694C (de)
DE (1) DE3750140D1 (de)
DK (1) DK199788A (de)
GR (1) GR871277B (de)
WO (1) WO1988001169A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503919A (ja) * 1989-06-13 1993-06-24 スミスクライン・ビーチャム・コーポレイション 単球および/またはマクロファージによるインターロイキン―1または腫瘍壊死因子生成の抑制
WO1990015534A1 (en) * 1989-06-13 1990-12-27 Smithkline Beecham Corporation Monokine activity interference
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
EP0489690A1 (de) * 1990-12-05 1992-06-10 Ciba-Geigy Ag Substituierte N-Benzoyl-N'-(2-phenylethyl)-piperazine
GB9026926D0 (en) * 1990-12-12 1991-01-30 Smith Kline French Lab Novel process
US6156304A (en) * 1990-12-20 2000-12-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education Gene transfer for studying and treating a connective tissue of a mammalian host
US5858355A (en) * 1990-12-20 1999-01-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education IRAP gene as treatment for arthritis
US6413511B1 (en) 1990-12-20 2002-07-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide
US6159464A (en) * 1990-12-20 2000-12-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
US6228356B1 (en) 1990-12-20 2001-05-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
JPH06502178A (ja) * 1990-12-31 1994-03-10 藤沢薬品工業株式会社 イミダゾトリアジン誘導体
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
NZ274063A (en) * 1993-09-17 1997-11-24 Smithkline Beecham Corp Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use
US5783664A (en) * 1993-09-17 1998-07-21 Smithkline Beecham Corporation Cytokine suppressive anit-inflammatory drug binding proteins
US5552422A (en) * 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
KR20000057137A (ko) 1996-11-19 2000-09-15 스티븐 엠. 오드레 아릴 및 헤테로아릴로 치환된 융합 피롤 항염증제
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
US7186714B2 (en) * 2001-06-21 2007-03-06 Smithkline Beecham Corporation Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
ES2262893T3 (es) 2001-10-05 2006-12-01 Smithkline Beecham Corporation Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
CA2526285A1 (en) 2003-05-15 2004-12-23 Arqule, Inc. Inhibitors of p38 and methods of using the same
WO2006010082A1 (en) * 2004-07-08 2006-01-26 Arqule, Inc. 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
EP2258704A1 (de) * 2004-10-19 2010-12-08 ArQule, Inc. Synthese aus Imidazooxazol- und Imidazothiazol-hemmern der P38-map-kinase
BRPI0921862A2 (pt) * 2008-12-05 2015-12-29 Arqule Inc inibidores de raf e seus usos
EP3791880A1 (de) 2009-04-29 2021-03-17 Amarin Pharmaceuticals Ireland Limited Pharmazeutische zusammensetzungen enthaltend epa
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
US4064260A (en) * 1976-07-29 1977-12-20 E. I. Du Pont De Nemours And Company Anti-inflammatory diarylimidazothiazoles and their corresponding S-oxides
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
US4153706A (en) * 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
GB2039882A (en) * 1979-01-05 1980-08-20 Ciba Geigy Ag Bicyclic thiadiaza compounds and their use as medicaments
US4186205A (en) * 1979-01-08 1980-01-29 Smithkline Corporation 2,3-Di(4-substituted phenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazoles
US4507481A (en) * 1983-07-29 1985-03-26 Pennwalt Corporation Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines

Also Published As

Publication number Publication date
WO1988001169A1 (en) 1988-02-25
ATE107507T1 (de) 1994-07-15
AU7880087A (en) 1988-03-08
EP0321490A1 (de) 1989-06-28
US4794114A (en) 1988-12-27
CA1292694C (en) 1991-12-03
EP0321490A4 (de) 1990-05-14
GR871277B (en) 1987-12-18
EP0321490B1 (de) 1994-06-22
JPH01503782A (ja) 1989-12-21
DK199788D0 (da) 1988-04-12
DK199788A (da) 1988-04-12

Similar Documents

Publication Publication Date Title
DE3750140D1 (de) Inhibierung der interleukin-1-bildung durch monocyten und/oder makrophagen.
ES2007292B3 (es) Ajustes de tuberia de cierre propio de rapida accion
NL192924B (nl) ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan.
FI821240A0 (fi) Med dubbelmod fungerande maetaravlaesningsanordning
ES288846Y (es) Valvula de compuerta
AR229372A1 (es) Valvula de compuerta deslizante
IT1147843B (it) Composizione analgesica ad effetto sinergistico
FI832865A0 (fi) Ettstegs hoegtryckscentrifugalpump foer slam
IT8119165A0 (it) Perossidi organici e loro applicazione.
DE3650041T2 (de) Hemmung von Stoffwechselweg von 5-Lipoxygenasen.
TR24358A (tr) Birden fazla insa asamasinda kurulabilen pis su aritma tesisi.
IT8122017A0 (it) Dado o manicotto di serraggio con zone elastiche.
DE3689712T2 (de) NOR-Gatter mit Festlegung des niedrigen logischen Ausgangswertes.
IT8419298A0 (it) Dado di rotolamento chiuso.
NL183796C (nl) Zelfsluitend voerhek.
AR226668A1 (es) Valvula de compuerta
IT8168143A0 (it) Composto per il trattamento e la prevenzione della diarrea in animali
DK201480A (da) Baerebeslag til rullestokke
ES287573Y (es) Purgador termostatico-bimetalico con regulador de doble ac- cion compensada
NO148423C (no) Sluseventil
ES258600Y (es) Jarro perfeccionado
ES280352Y (es) Valvula de seguridad con paso de doble compuerta
ES280735Y (es) Desague perfeccionado.
FI841705A0 (fi) Tork.
IT8111786V0 (it) Dado elettronico

Legal Events

Date Code Title Description
8332 No legal effect for de